Insmed Stock Forecast

Stock Price Forecast

According to 22 analysts polled by S&P Global, Insmed stock has a consensus rating of "Strong Buy" and an average price target of $197.05. The average 1-year stock price forecast is 70.44% higher than the current stock price, while the lowest is $140 (+21.10%) and the highest is $243 (+110.19%).

Price Target: $197.05 (+70.44%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$140	$197.05	$200	$243
Change	+21.10%	+70.44%	+73.00%	+110.19%

Analyst Ratings

The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	17	17	17	17	17	17
Buy	2	3	4	5	5	5
Hold	1	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	20	20	21	22	22	22

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Vamil Divan Guggenheim	Guggenheim	Buy Reiterates $226 → $207	Buy	Reiterates	$226 → $207	+79.05%	Jul 10, 2026
Faisal Khurshid Jefferies	Jefferies	Buy Maintains $175	Buy	Maintains	$175	+51.37%	Jul 7, 2026
Maxwell Skor Morgan Stanley	Morgan Stanley	Buy Maintains $212	Buy	Maintains	$212	+83.38%	Jul 7, 2026
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $195	Buy	Maintains	$195	+68.67%	Jul 7, 2026
Ritu Baral TD Cowen	TD Cowen	Buy Maintains $243	Buy	Maintains	$243	+110.19%	Jun 16, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.69B

from 606.42M

178.13%

from 606.42M

Revenue Next Year

2.73B

from 1.69B

62.15%

from 1.69B

EPS This Year

-2.69

from -6.42

EPS Next Year

0.12

from -2.69

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	188.46M	245.36M	305.21M	363.71M	606.42M	1.69B
Revenue Growth	14.63%	30.19%	24.39%	19.17%	66.73%	178.13%
Gross Profit	144.31M	190.23M	239.64M	277.97M	483.49M	1.40B
Gross Margin	76.57%	77.53%	78.52%	76.43%	79.73%	83.14%
Operating Income	-367.16M	-478.12M	-680.93M	-786.57M	-994.78M	-538.62M
Net Income	-434.65M	-481.53M	-749.57M	-913.77M	-1.28B	-578.87M
EPS	-	-	-	-	-6.42	-2.69
Free Cash Flow	-181.08M	-199.98M	-384.98M	-418.30M	-564.05M	-461.02M
No. Analysts	-	-	-	-	-	20

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	1.8B
Avg	1.7B
Low	1.6B

Revenue Growth

Revenue Growth	2026	2027	2028
High	191.9%
Avg	178.1%
Low	165.4%

EPS Forecast

EPS	2026	2027	2028
High	-1.67
Avg	-2.69
Low	-4.29

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-